Symptoms and General Pathology

All Conditions

Nervous System Diseases

Musculoskeletal Diseases

Neoplasms

Skin and Connective Tissue Diseases

Hernia

Pain

Constriction, Pathologic

Radiculopathy

Intervertebral Disc Displacement

Intervertebral Disc Degeneration

Spondylolisthesis

Spinal Stenosis

Cysts

Ganglion Cysts

Synovial Cyst

Spondylosis

Peripheral Nervous System Diseases

Neuromuscular Diseases

Spinal Diseases

Bone Diseases

Pathological Conditions, Anatomical

Spondylolysis

Central Nervous System Depressants

All Drugs and Chemicals

Pharmaceutical Solutions

Vasoconstrictor Agents

Respiratory System Agents

Antihypertensive Agents

Analgesics

Anesthetics

Bupivacaine

Epinephrine

Racepinephrine

Epinephryl borate

Clonidine

Anesthetics, Local

Adrenergic Agents

Adrenergic alpha-Agonists

Adrenergic Agonists

Neurotransmitter Agents

Adrenergic beta-Agonists

Bronchodilator Agents

Anti-Asthmatic Agents

Mydriatics

Sympathomimetics

Sympatholytics

Patients will undergo regional ESPB with bupivacaine plus clonidine in the holding area of the OR immediately prior to surgery. 30mL of 0.25% bupivacaine/1:200,000 epinephrine/50mcg clonidine will be administered bilaterally (total 60ml) to the lumbar paraspinal erector spine plane using ultrasound-guidance.

Patients will receive a placebo injection of normal saline via the same ESPB technique. 30ml of normal saline will be administered bilaterally (total 60ml) to the lumbar paraspinal erector spine plane using ultrasound-guidance.

Bupivacaine-Epinephrine 0.25%-1:200,000 plus clonidine 50 micrograms in 30cc syringes administered as ESPB

Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine

normal saline in 30cc syringes administered using ESPB technique

normal saline

Bart Jacher

Morgan Mulcahy

John O'Toole, MD

Opioid overuse is a widespread public health crisis in the United States with increasing rates of addiction and overdose deaths from prescription opioids. Reducing the need for opiate analgesics in the post-operative setting has become a high priority in minimizing long-term opioid use in surgical patients. This study will serve to demonstrate the efficacy of the addition of regional analgesic techniques in reducing post-operative opioid requirements in patients undergoing common lumbar spinal surgical procedures.

Opioid abuse and misuse remain a public health crisis in the United States, notably in patients with chronic pain from degenerative spine disease. Perioperative pain management for patients undergoing spinal surgery remains largely reliant on opioid medications, with several known adverse effects including, but not limited to delirium, postoperative urinary retention (POUR), constipation and nausea. These side effects contribute to increased hospital length of stay (LOS) with increased incidence of overall in-hospital complications, perioperative costs, and increased rates of opioid habituation and addiction.

Dependence on prescription opioids has been associated with wide-ranging social and economic consequences including increased opioid overdose resulting in death, growing opioid-related incarcerations, and spiraling opioid-related healthcare cost from treatment of addiction, opioid-related mental health issues, and debilitating chronic pain. Long-term requirements for opioid medications may be associated with the use of higher doses of opioids in the perioperative period for patients undergoing invasive surgery for spinal degenerative conditions. Studies have demonstrated that patients who consume fewer opioids for 30 days after surgery are less likely to progress to become chronic opioid users. Regional analgesic techniques have shown promise in decreasing post-operative pain and opioid requirements in thoracic and abdominal surgery but difficulties with post-operative neurological assessments have limited their use in spinal surgery. Inter-fascial plane blocks, however, have emerged as a safe and potentially useful regional analgesic technique to mitigate the pain-inducing effects of posterior spine surgery.

Erector Spinae Plane Blocks (ESPBs), specifically, involve ultra-sound guided injection of local anesthetic (LA) posteriorly beneath the erector spinae muscles resulting in longitudinal and ventrolateral spread of the anesthetic into the paravertebral space where the ventral and dorsal rami of the spinal nerves are located thereby inducing a multi-level analgesic effect. Depending upon the LA used, this effect may last for 4 to 36 hours.

The proposed study will examine the efficacy of preoperative ESPBs in reducing post-operative opioid utilization and its associated complications specifically after minimally invasive (MIS) lumbar spine surgery including both decompressive and instrumented fusion procedures. The guiding principle of MIS spine surgery is reduction of iatrogenic injury by utilizing muscle dilating approaches and tubular retractors rather than conventional open, subperiosteal muscle stripping techniques. The latter typically results in muscle denervation and devascularization as well as postoperative muscle atrophy and dead space creation that increase postoperative pain, muscle dysfunction, prolonged recovery times and complications. Since MIS spinal surgical procedures preserve normal paraspinal musculature compared to open surgery, the magnitude of effect of ESPBs may actually be more pronounced in this population.

The investigators hypothesize that by conducting this investigation within the rigor of a double-blinded, randomized placebo-controlled clinical trial, the results will definitively demonstrate that the addition of regional analgesia in the form of ESPB during MIS lumbar spine surgery will 1) reduce post-operative opioid consumption and 2) reduce opioid-related complications and hospital LOS but 3) have no adverse effects on postoperative pain control.

All patients will undergo surgery using an enhanced recovery after surgery (ERAS) multi-modal anesthesia protocol that is currently in standard use for MIS lumbar spine surgical procedures. Patients will be randomized in a 1:1 ratio to investigational and control arms.

Patients, surgeons and anesthesiologists will all be blinded to treatment allocation. Syringes containing the fluid to be injected will be prepared by pharmacy and labeled with subject number in such a manner to blind the anesthesiologist performing the ESPB to its contents.

Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery

Randomized, Placebo-controlled Trial of Erector Spinae Plane Blocks (ESPB) for Perioperative Pain Management for Minimally Invasive (MIS) Lumbar Spine Surgery

Mean per day inpatient opioid consumption in morphine milligram equivalents (MME)

Total and per day mean postoperative opioid consumption after hospital discharge in MME as recorded in medication diary by patients

• Total MMEs of opioid prescriptions filled as found on the Illinois Prescription Monitoring Program website

Duration of hospital stay postoperatively measured in days as determined by the time at which each patient met discharge criteria

Incidence of POUR measured as proportion of inpatient hospital days demonstrating the need for straight catheterization or foley placement

Incidence of post-operative delirium as measured by the need for placement of physical restraints

Incidence of post-operative delirium as measured by the administration of new anti-psychotic medications

Mean daily VAS (visual analog scale) pain scores recorded in the electronic medical record (EMR)

Change in Visual Analog Scale (VAS) for pain in the back and leg (0-10 with 10 being worst)

Change in Oswestry Disability Index (ODI; 0 to 100 with 100 being worst)

Change in Short Form 12/6D (SF-12/6D; 0 to 100 with 0 being worst)

Prospectively documented medical and surgical complications/adverse events (AEs) including rates of readmission or reoperation for AEs

Spots Global Cancer Trial Database for minimally invasive spine surgery